Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 28, 2005; 11(4): 482-487
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.482
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.482
Gender | Genotype | Anti-LKM titre | Response | |||
1st | 2nd | 3rd | End of treatment | End of follow-up | ||
M | 1b | 1/320 | 1/40 | 0 | Responder | Sustained responder |
F | 1b | 1/40 | 1/160 | 1/80 | Responder | Relapser |
F | 2a/c | 1/40 | 1/40 | 1/40 | Non-responder | Non-responder |
M | 4 | 0 | 1/160 | 1/80 | Non-responder | Non-responder |
- Citation: Gatselis NK, Georgiadou SP, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, Dalekos GN. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study. World J Gastroenterol 2005; 11(4): 482-487
- URL: https://www.wjgnet.com/1007-9327/full/v11/i4/482.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i4.482